CONSOLIDATED BALANCE SHEETS - CONTINUED - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current liabilities
Accounts payable	$ 21	$ 28
Accrued expenses	36	32
Total current liabilities	57	60
Stockholders' equity
Preferred stock, Series B	1	1
Common stock, $.01 par value; authorized, 100,000,000 shares; issued and outstanding, 5,131,934 shares at September 30, 2022 and December 31, 2021	51	51
Additional paid-in capital	63,579	63,579
Accumulated deficit	(59,066)	(59,236)
Total shareholder equity	4,565	4,395
Total liabilities & equity	$ 4,622	$ 4,455